From Cyborg Anthropology
Jump to: navigation, search


OncoMouse is both a noun and a trademark. OncoMouse describes a transgenic mouse carrying an activated human cancer gene, used in laboratory experiments.[1] Philip Leder and Timothy A Stewart[2] of Harvard University designed the mouse to carry an activated oncogene, a gene that in certain circumstances can transform a cell into a tumor cell. This makes suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.[3]

OncoMouse was also the first patented animal. Two patents were awarded to Harvard College describing methods for "providing a cell culture from a transgenic non-human animal".[4]

Related Reading

  • Modest_Witness@Second_Millennium.FemaleMan©Meets_OncoMouse™: Feminism and Technoscience, New York: Routledge, 1997 (winner of the Ludwig Fleck Prize). ISBN 0-415-91245-8.


  1. New Oxford American Dictionary. 2011.
  2. European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.
  3. Trademark: USPTO serial number 75797027
  4. U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene, U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016.